VELOX^® MCS microcrystalline starch is a proprietary new excipient for the preparation of pharmaceutical pellets which enables rapid and complete release of poorly soluble drugs.  VELOX MCS disintegrates rapidly in the GI tract in contrast to microcrystalline cellulose.  VELOX MCS has the requisite physical properties to produce smooth, uniform spheres via the extrusion-spheronization process. 

The spheres can be produced in high yield with low friability and are suitable for enteric coating.  VELOX MCS conforms to the USP monograph.  This technology is available for collaborative developments and/or license.  For further information, please contact Dr. Paul Foreman, paul.foreman@us.henkel.com or Tel: +1 908.685.5456.